Your session is about to expire
← Back to Search
Behavioural Intervention
Tele-Exergaming for Mild Cognitive Impairment
N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to walk at least 30 feet with or without assistance
Living independently in a residential home with a caregiver/informant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4, week 8, week 12
Awards & highlights
Study Summary
This trial is looking at whether or not a specifically designed in-home exercise system can improve balance and cognition in adults with mild cognitive impairment or mild dementia.
Who is the study for?
This trial is for adults who can walk at least 30 feet, with or without help, and have been diagnosed with dementia or mild cognitive impairment. They should live independently but have a caregiver available. It's not suitable for those with severe cognitive issues (MoCA score <16), major mobility disorders, or significant hearing/vision impairments.Check my eligibility
What is being tested?
The study tests a remote exercise program using a Tele-Exergame Platform to improve balance and cognition in older adults with memory problems. Participants will use this system at home while being monitored remotely, as opposed to not using the platform.See study design
What are the potential side effects?
Since this is an exercise-based intervention, potential side effects may include muscle soreness, fatigue, and risk of falls during activity. However, these are common risks associated with physical exercise programs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can walk at least 30 feet by myself or with help.
Select...
I live at home and have someone who helps take care of me.
Select...
I have been diagnosed with dementia or cognitive impairment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 4, week 8, week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4, week 8, week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Balance
Change in Cognitive Function
Change in Fear of Falling
Secondary outcome measures
Change in Gait speed
Change in Physical Activity
Change in Quality of Life
+1 moreOther outcome measures
Adherence
Supportive care acceptability
intervention related dropout
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Remote Exercise with tele-exergameActive Control1 Intervention
Subjects will perform exercises remotely twice a week with tele-exergaming platform.
Group II: home-based exercise without technologyPlacebo Group1 Intervention
Subjects will perform exercises at home without tele-exergaming platform twice a week.
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,006 Previous Clinical Trials
6,003,092 Total Patients Enrolled
BioSensicsIndustry Sponsor
15 Previous Clinical Trials
1,047 Total Patients Enrolled
BioSensics LLCUNKNOWN
4 Previous Clinical Trials
360 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have severe problems with memory and thinking.I can walk at least 30 feet by myself or with help.I have significant hearing or vision loss.I cannot move well enough to safely do weight-bearing exercises.I live at home and have someone who helps take care of me.I have been diagnosed with dementia or cognitive impairment.
Research Study Groups:
This trial has the following groups:- Group 1: Remote Exercise with tele-exergame
- Group 2: home-based exercise without technology
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger